BioCentury
ARTICLE | Company News

Oxford BioMedica management update

June 10, 2013 7:00 AM UTC

Oxford BioMedica plc (LSE:OXB), Oxford, U.K. Business: Cancer, Gene/Cell therapy, Neurology Departing: Stuart Naylor as CSO and a director Hired: Madhu Davies, an Oxford BioMedica consultant, as CMO, ...